PRICE T ROWE ASSOCIATES INC /MD/
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$232,478,522
+$37,966,908 QoQ
Shares Held
6,212,681
+16.0% QoQ
Ownership
5.86%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. CRNX ranks #21 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,478,522 | 6,212,681 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $194,511,614 | 5,355,496 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $243,195,214 | 5,224,387 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $221,005,228 | 5,306,248 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $160,782,894 | 5,590,504 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $171,468,553 | 5,112,360 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $276,843,640 | 5,414,505 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $252,677,082 | 4,944,757 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $197,365,164 | 4,406,456 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $178,964,834 | 3,823,218 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $107,055,166 | 3,008,858 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $76,675,637 | 2,578,199 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,748,957 | 1,428,910 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $671,034 | 41,783 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $950,337 | 51,931 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,210,511 | 61,635 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,014,690 | 54,407 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $824,946 | 37,583 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,182,513 | 76,822 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,392,731 | 66,163 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,242,686 | 65,925 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $746,657 | 48,865 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,141,527 | 80,902 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,348,685 | 86,068 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,507,911 | 86,068 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $417,597 | 28,408 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||